Chemed Corp’s recent filing unveils that its Director RICE THOMAS P acquired Company’s shares for reported $0.23 million on Jul 31 ’25. In the deal valued at $418.01 per share,556 shares were bought.
Then, MCNAMARA KEVIN J sold 2,000 shares, generating $857,100 in total proceeds. Upon selling the shares at $428.55, the president and CEO now owns 99,197 shares.
Before that, MCNAMARA KEVIN J bought 2,000 shares. Chemed Corp shares valued at $857,460 were divested by the Officer at a price of $428.73 per share.
Jefferies initiated its Chemed Corp [CHE] rating to a Hold in a research note published on July 25, 2025; the price target was $500. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in mid March from “a Sector perform” to “an Outperform”. JMP Securities also remained covering CHE and has increased its forecast on November 01, 2019 with a “Mkt outperform” recommendation from previously “Mkt perform” rating. BofA/Merrill maintained its rating on September 06, 2019. It rated CHE as “a Buy”.
Price Performance Review of CHE
On Friday, Chemed Corp [NYSE:CHE] saw its stock jump 1.34% to $457.95. Over the last five days, the stock has lost -0.24%. Chemed Corp shares have fallen nearly -19.27% since the year began. Nevertheless, the stocks have fallen -13.56% over the past one year. While a 52-week high of $623.60 was reached on 04/03/25, a 52-week low of $408.42 was recorded on 08/01/25.
Levels Of Support And Resistance For CHE Stock
The 24-hour chart illustrates a support level at 454.98, which if violated will result in even more drops to 452.01. On the upside, there is a resistance level at 460.44. A further resistance level may holdings at 462.93.
How much short interest is there in Chemed Corp?
A steep rise in short interest was recorded in Chemed Corp stocks on 2025-08-15, growing by 0.12 million shares to a total of 0.51 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 0.39 million shares. There was a rise of 24.3%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 12, 2018 when BofA/Merrill began covering the stock and recommended ‘”a Buy”‘ rating along with a $390 price target.
